Nusinersen improves motor function of children with SMA
Clinical trial shows treatment is effective for children with spinal muscular atrophy...
List view / Grid view
News
TB vaccine trial results offer potential for BCG revaccination
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
Psoriasis drug found to reduce aortic vascular inflammation
An antibody used to treat the skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events...
The future of cell culture: A new continuous bioprocess developed
A technique which allows the continuous production and collection of a cell has been developed removing the limit on the number of cells that can be grown in a culture dish...
We are proud to announce the opening of our North America office: Exciting times for FPS
In order to support the continued growth of our business in North America, FPS opened a new office in Philadelphia, PA and appointed Frederic Le Pape as General Manager...
Short-acting asthma relievers linked to infertility
New research indicates that women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women...
NICE approves Lenvima for differentiated thyroid cancer
NICE has issued its final appraisal decision recommending reimbursement of Lenvima for the treatment of progressive, locally advanced or metastatic, differentiated thyroid carcinoma...
Individual Inks by Hapa Ink
Hapa Ink is a division of Hapa, the innovative on demand printing specialist. It is experiencing a rapid increase in demand of sales for individually developed inks...
Wickham Labs to exhibit at inaugural Making Pharmaceuticals Europe Conference 2018
Wickham Laboratories Ltd will exhibit on Stand 408 at the Making Pharmaceuticals Europe Conference, from the 13 - 14 March 2018 in Belgium at Brussels Expo centre...
Novartis forms alliance to develop medicines for cryptosporidiosis
Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance the development of Novartis' drug candidate KDU731...
Gore to debut GORE™ ImproJect™ plunger for sensitive biologics in pre-filled syringes
NEWARK, Del. – W.L. Gore & Associates, Inc. (“Gore”), a global materials science company, will introduce its new GORE™ ImproJect™ Plunger at Pharmapack 2018, Europe's dedicated pharmaceutical packaging and drug delivery event. Gore will be in Booth A12 at the exhibition, to be held February 7 and 8, 2018, at…
First comparison of common breast cancer tests finds varied accuracy of predictions
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
Heroin vaccine blocks lethal overdose
Scientists have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug...
Cabozantinib shows promise as first line treatment for differentiated thyroid cancer
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer...
Nicotinamide riboside repairs features of Alzheimer’s disease
Researchers have found that an NAD+ precursor helped mice with features of Alzheimer’s disease perform better on learning and memory tests...
